$SOPH News

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2026 on November 3, 2026

HC Wainwright & Co. Reiterates Buy on Sophia Genetics, Maintains $14 Price Target

SOPHiA Genetics: Scaling Phase Begins As U.S. And Pharma Monetization Inflect

SOPHiA GENETICS (SOPH) Stock Sees Modest Fair Value Lift After Q2 Guidance Raise

SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript

AstraZeneca (LSE:AZN) Signs Two Cancer Diagnostics Deals To Widen Patient Access

SOPHiA GENETICS SA 2026 Q2 - Results - Earnings Call Presentation

SOPHiA GENETICS partners with AstraZeneca for oncology diagnostics

HC Wainwright & Co. Maintains Buy on Sophia Genetics, Raises Price Target to $14

BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $9

Sophia Genetics SA (SOPH) (Q2 2026) Earnings Call Highlights: Record Revenue Growth and ...

SOPHiA GENETICS Q2 Earnings Call Highlights

SOPHiA GENETICS SA (SOPH) Q2 2026 Earnings Call Transcript

SOPH Stock Heads For Best Day In Over 8 Months – What’s Driving Today’s Super Rally?

SOPHiA GENETICS (NASDAQ:SOPH) Beats Q2 Revenue Estimates, Shares Rise Despite Wider Loss

SOPHiA GENETICS Reports Second Quarter 2026 Results

SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies

SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies

Sophia Genetics Raises FY2026 Sales Guidance from $92.000M-$94.000M to $94.000M-$96.000M vs $93.403M Est

Sophia Genetics Q2 EPS $(0.30) Misses $(0.20) Estimate, Sales $23.310M Beat $21.729M Estimate